We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$238M
AUM Growth
-$511K
Cap. Flow
-$5.96M
Cap. Flow %
-2.51%
Top 10 Hldgs %
56.07%
Holding
204
New
16
Increased
9
Reduced
10
Closed
19
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.7 years
Top 20 Avg Time Held Equity + Options
0.6 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.7 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
CDXS icon
Codexis
CDXS
+$1.79M
2
GSK icon
GSK
GSK
+$1.52M
3
FIP icon
FTAI Infrastructure
FIP
+$1.21M
4
FSTX
F-star Therapeutics, Inc. Common Stock
FSTX
+$1.01M
5
AVDL
Avadel Pharmaceuticals
AVDL
+$920K

Top Sells

Rank Stock Value
1
BHVN icon
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$3.65M
2
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
+$3.07M
3
INCY icon
Incyte
INCY
+$2.04M
4
INVA icon
Innoviva
INVA
+$1.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.48M

Sector Composition

Rank Sector Weight
1 Healthcare 32.63%
2 Materials 25.45%
3 Miscellaneous 11.79%
4 Financials 10.86%
5 Real Estate 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AVDL
26
DELISTED
Avadel Pharmaceuticals
AVDL
$1.96M 0.82%
390,861
+167,081
+75% +$920K
2021 Q4
3 quarters
CHRS icon
27
Coherus Oncology
CHRS
$161M
$1.92M 0.81%
200,000
+13,866
+7% +$140K
2021 Q4
3 quarters
TWLVW icon
28
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.92M 0.81%
166,666
– –
2021 Q4
3 quarters
EXE icon
29
Expand Energy Corp
EXE
$21.6B
$1.88M 0.79%
20,000
– –
2022 Q2
1 quarter
RHP icon
30
Ryman Hospitality Properties
RHP
$8.77B
$1.8M 0.76%
24,400
– –
2021 Q4
3 quarters
AB icon
31
AllianceBernstein
AB
$3.2B
$1.77M 0.75%
50,500
– –
2021 Q4
3 quarters
MOS icon
32
The Mosaic Company
MOS
$5.98B
$1.69M 0.71%
35,000
– –
2022 Q2
1 quarter
BIP icon
33
Brookfield Infrastructure Partners
BIP
$17.1B
$1.62M 0.68%
45,000
– –
2022 Q1
2 quarters
OVV icon
34
Ovintiv
OVV
$18.8B
$1.61M 0.68%
35,000
– –
2022 Q2
1 quarter
KAIRW
35
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.6M 0.67%
139,278
– –
2021 Q4
3 quarters
TECK icon
36
Teck Resources
TECK
$32.2B
$1.52M 0.64%
50,000
– –
2022 Q2
1 quarter
CLMT icon
37
CALL
Calumet Specialty Products
CLMT
$5.01B
$1.47M 0.62%
+115,000
New +$1.65M
2022 Q3
0 quarters
CVE icon
38
Cenovus Energy
CVE
$59.9B
$1.46M 0.61%
95,000
– –
2022 Q2
1 quarter
BBIO icon
39
BridgeBio Pharma
BBIO
$12.9B
$1.42M 0.6%
143,096
-70,110
-33% -$728K
2022 Q1
2 quarters
CDXS icon
40
Codexis
CDXS
$141M
$1.35M 0.57%
+222,107
New +$1.79M
2022 Q3
0 quarters
BRIVW
41
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$1.34M 0.56%
116,666
– –
2021 Q4
3 quarters
FSTX
42
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.21M 0.51%
235,945
+160,491
+213% +$1.01M
2022 Q2
1 quarter
GSK icon
43
GSK
GSK
$99.4B
$1.18M 0.5%
+40,000
New +$1.52M
2022 Q3
0 quarters
PMGMW icon
44
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.15M 0.48%
100,000
– –
2021 Q4
3 quarters
GMED icon
45
Globus Medical
GMED
$10.5B
$1.12M 0.47%
18,831
– –
2021 Q4
3 quarters
INCY icon
46
Incyte
INCY
$23B
$1.08M 0.46%
16,257
-27,563
-63% -$2.04M
2021 Q4
3 quarters
FIP icon
47
FTAI Infrastructure
FIP
$286M
$1.02M 0.43%
+425,000
New +$1.21M
2022 Q3
0 quarters
WPC icon
48
W.P. Carey
WPC
$14.8B
$838K 0.35%
12,252
– –
2021 Q4
3 quarters
LOKM.WS
49
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
$828K 0.35%
72,030
– –
2021 Q4
3 quarters
VKTX icon
50
Viking Therapeutics
VKTX
$3.33B
$821K 0.35%
301,803
+35,000
+13% +$115K
2021 Q4
3 quarters
1
2
3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q3 2022 Portfolio in Review

As of Q3 2022, David M. Knott Jr held 204 positions worth $238M, down 0.21% from $238M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

David M. Knott Jr's Q3 2022 filing shows 16 new, 9 increased, 10 reduced and 19 closed positions. Its largest new stake was Codexis: 222,107 shares worth $1.35M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $3.65M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Materials and Miscellaneous.

  • David M. Knott Jr's largest Q3 2022 buy was Codexis: 222,107 shares worth $1.35M.
  • David M. Knott Jr added most to F-star Therapeutics, Inc. Common Stock in Q3 2022, an estimated $1.01M increase.
  • David M. Knott Jr's biggest Q3 2022 reduction was Incyte, cutting an estimated $2.04M.
  • David M. Knott Jr fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $3.65M.
  • David M. Knott Jr's ten largest holdings make up 56% of its $238M portfolio in Q3 2022.
  • David M. Knott Jr opened 16 new positions and closed 19 in Q3 2022.
  • David M. Knott Jr's portfolio value fell 0.21% quarter-over-quarter to $238M.

Based on David M. Knott Jr's 13F filing for Q3 2022, filed 10 Nov 2022.